BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 34887632)

  • 21. [The importance of mutational status in prognosis and therapy of GIST].
    Comandone A; Boglione A
    Recenti Prog Med; 2015 Jan; 106(1):17-22. PubMed ID: 25621775
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Update on Gastrointestinal Stromal Tumors for Radiologists.
    Tirumani SH; Baheti AD; Tirumani H; O'Neill A; Jagannathan JP
    Korean J Radiol; 2017; 18(1):84-93. PubMed ID: 28096720
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Update on the biology and therapy of gastrointestinal stromal tumors.
    D'Amato G; Steinert DM; McAuliffe JC; Trent JC
    Cancer Control; 2005; 12(1):44-56. PubMed ID: 15668652
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting c-kit mutations in solid tumors: scientific rationale and novel therapeutic options.
    Demetri GD
    Semin Oncol; 2001 Oct; 28(5 Suppl 17):19-26. PubMed ID: 11740803
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intratumoral KIT mutational heterogeneity and recurrent KIT/ PDGFRA mutations in KIT/PDGFRA wild-type gastrointestinal stromal tumors.
    Gao J; Li J; Li Y; Li Z; Gong J; Wu J; Liu N; Dong B; Qi C; Li J; Shen L
    Oncotarget; 2016 May; 7(21):30241-9. PubMed ID: 26848617
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical significance of the molecular heterogeneity of gastrointestinal stromal tumors and related research: A systematic review.
    Ding H; Yu X; Yu Y; Lao X; Hang C; Gao K; Jia Y; Yan Z
    Oncol Rep; 2020 Mar; 43(3):751-764. PubMed ID: 32020209
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A case of multiple gastrointestinal stromal tumors caused by a germline KIT gene mutation (p.Leu576Pro).
    Vale Rodrigues R; Santos F; Pereira da Silva J; Francisco I; Claro I; Albuquerque C; Lemos MM; Limbert M; Dias Pereira A
    Fam Cancer; 2017 Apr; 16(2):267-270. PubMed ID: 27771813
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gastrointestinal stromal tumors: diagnosis and treatment.
    Acín-Gándara D; Pereira-Pérez F; Castaño-Pascual A; Durán-Poveda M; Antequera-Pérez A; Miliani-Molina C
    Cir Cir; 2012; 80(1):44-51. PubMed ID: 22472152
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oncogene mutational analysis in imatinib naive population of gastrointestinal stromal tumor patients.
    Ali Abuderman AW; M Aldakheel F
    Cell Mol Biol (Noisy-le-grand); 2020 Dec; 66(8):26-32. PubMed ID: 34174973
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of Long-Term Adjuvant Therapy With Imatinib Mesylate After Extensive Surgical Treatment for Ruptured Gastrointestinal Stromal Tumors of the Small Intestine With Peritoneal Metastases: A Case Report.
    Kimura T; Togawa T; Onishi K; Iida A; Sato Y; Goi T
    J Investig Med High Impact Case Rep; 2020; 8():2324709620970736. PubMed ID: 33228387
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An Unexpected Response to Imatinib in a "Wild-Type" Gastrointestinal Stromal Tumor.
    Gheysen M; Vander Borght S; Lehnert S; Vanslembrouck R; Vanden Bempt I; Schöffski P
    Oncol Res Treat; 2020; 43(9):470-473. PubMed ID: 32640452
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proteogenomics for the Study of Gastrointestinal Stromal Tumors.
    Kondo T
    Adv Exp Med Biol; 2016; 926():139-151. PubMed ID: 27686810
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular basis and management of gastrointestinal stromal tumors.
    Bayraktar UD; Bayraktar S; Rocha-Lima CM
    World J Gastroenterol; 2010 Jun; 16(22):2726-34. PubMed ID: 20533592
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Imatinib treatment for gastrointestinal stromal tumour (GIST).
    Lopes LF; Bacchi CE
    J Cell Mol Med; 2010 Jan; 14(1-2):42-50. PubMed ID: 19968734
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gastrointestinal stromal tumors (GISTs): a pathology view point.
    Sornmayura P
    J Med Assoc Thai; 2009 Jan; 92(1):124-35. PubMed ID: 19260254
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of malignancy and prognosis of gastrointestinal stromal tumors: a review.
    Miettinen M; El-Rifai W; H L Sobin L; Lasota J
    Hum Pathol; 2002 May; 33(5):478-83. PubMed ID: 12094372
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Not Available].
    Hompland I; Hølmebakk T; Boye K; Stoldt S; Bjerkehagen B; Berner JM; Wiedswang AM; Revheim ME; Poulsen JP; Hall KS; Bruland ØS
    Tidsskr Nor Laegeforen; 2018 Oct; 138(15):. PubMed ID: 30277049
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gastrointestinal Stromal Tumors: Imaging Features Before and After Treatment.
    Milliron B; Mittal PK; Camacho JC; Datir A; Moreno CC
    Curr Probl Diagn Radiol; 2017; 46(1):17-25. PubMed ID: 26422114
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Activating mutations in receptor tyrosine kinases with relevance for treatment of gastrointestinal stromal tumors].
    Wardelmann E; Merkelbach-Bruse S; Büttner R; Schildhaus HU
    Verh Dtsch Ges Pathol; 2007; 91():165-8. PubMed ID: 18314611
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preoperative adjuvant therapy for locally advanced and recurrent/metastatic gastrointestinal stromal tumors: a retrospective study.
    Qi J; Liu HL; Ren F; Liu S; Shi W; Liu WH; Cai GQ; Liao GQ
    World J Surg Oncol; 2020 Apr; 18(1):70. PubMed ID: 32264886
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.